Send to

Choose Destination
See comment in PubMed Commons below
Biomed Imaging Interv J. 2006 Jul;2(3):e23. doi: 10.2349/biij.2.3.e23. Epub 2006 Jul 1.

Radioimmunotherapy: a brief overview.

Author information

Department of Nuclear Medicine and PET, Singapore General Hospital, Singapore.


With the advent of biotechnological advances and knowledge of molecular and cellular biology, radioimmunotherapy (RIT) has become a highly promising oncologic therapeutic modality with established clinically efficacy, particularly in non-Hodgkin's lymphomas. This paper provides a short survey of the basic science of RIT and the various monoclonal antibodies and radionuclides used. A brief review of the published literature on the clinical applications of radioimmunotherapy, particularly in non-Hodgkin's lymphoma, is provided. New research data indicate many potential areas of development of this modality, including haematological and solid-organ radioimmunotherapy as well as new radionuclidic approaches and clinical protocols.


Monoclonal antibodies; ibritumomab tiuxetan; oncology; tositumomab

PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center